Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

Serratus block vs ESP block for pain after unilateral breast surgery

Official title: Comparison of Serratus Posterior Superior Intercostal Plane Block and Erector Spinae Plane Block for Postoperative Analgesia in Unilateral Breast Surgery: A Prospective, Randomized, Assessor-Blinded Trial

Run by Kocaeli City Hospital · NCT07541040 · Data updated 2026-11-12

This trial tests whether the serratus posterior superior intercostal plane block (SPSIPB) provides similar or better pain relief than the erector spinae plane block (ESPB) after unilateral breast surgery in adult women.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment54 (estimated)
SponsorKocaeli City Hospital
Government
Locations1 site (İzmit, Kocaeli)
StatusRecruiting
StartedMay 1, 2026
Main results expectedNovember 1, 2026
Study endsNovember 1, 2026
Registry record updatedSeptember 30, 2026
Trial IDNCT07541040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult women (18-65) with ASA I-III undergoing elective unilateral breast surgery, without contraindications to regional anesthesia or chronic opioid use.

Probably not a fit

Patients with infections at the block site, known local anesthetic allergy, coagulopathy, pregnancy, or those requiring additional intraoperative analgesia outside the protocol may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, assessor-blinded study at a single center that assigns 54 adult female patients to receive either SPSIPB or ESPB under ultrasound guidance before anesthesia for unilateral breast surgery. All participants follow standardized general anesthesia and multimodal postoperative analgesia. Pain is measured with the Numerical Rating Scale during the first 24 hours, at rest and with movement, to compare analgesic effectiveness and total opioid use between groups.

Why it matters

Potential benefit: If SPSIPB provides equal or better analgesia, patients may experience better early postoperative pain control and potentially reduced opioid needs.

How similar studies have gone: Prior research has explored regional blocks for breast surgery, with mixed results; this study tests SPSIPB against ESPB in a rigorous randomized design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 18-65 years
* ASA physical status I-III
* Body mass index (BMI) between 18 and 35 kg/m²
* Scheduled for elective unilateral breast surgery (mastectomy with or without sentinel lymph node biopsy)
* Ability to understand and provide written informed consent

Exclusion Criteria:

* Infection at the site of block application
* Known allergy to local anesthetics
* Coagulopathy or anticoagulant therapy
* Chronic opioid use
* Pregnancy
* Inability to communicate or cooperate
* Refusal to participate
* Failed block
* Requirement of additional intraoperative analgesia outside the study protocol
* Development of serious intraoperative complications

Where it's running

  • University of Health Sciences Kocaeli City Hospital
    İzmit, Kocaeli, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Engin Çetin, M.D — Kocaeli City Hospital
  • Study coordinator: Engin Çetin, M.D.
  • Email: Doccetin52@gmail.com
  • Phone: 5321206004

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.